1. Home
  2. PSNL vs BXC Comparison

PSNL vs BXC Comparison

Compare PSNL & BXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSNL
  • BXC
  • Stock Information
  • Founded
  • PSNL 2011
  • BXC 2004
  • Country
  • PSNL United States
  • BXC United States
  • Employees
  • PSNL N/A
  • BXC N/A
  • Industry
  • PSNL Medical Specialities
  • BXC Wholesale Distributors
  • Sector
  • PSNL Health Care
  • BXC Consumer Discretionary
  • Exchange
  • PSNL Nasdaq
  • BXC Nasdaq
  • Market Cap
  • PSNL 518.8M
  • BXC 574.9M
  • IPO Year
  • PSNL 2019
  • BXC 2004
  • Fundamental
  • Price
  • PSNL $10.01
  • BXC $70.66
  • Analyst Decision
  • PSNL Strong Buy
  • BXC Strong Buy
  • Analyst Count
  • PSNL 5
  • BXC 3
  • Target Price
  • PSNL $8.70
  • BXC $91.00
  • AVG Volume (30 Days)
  • PSNL 1.3M
  • BXC 64.8K
  • Earning Date
  • PSNL 11-04-2025
  • BXC 11-04-2025
  • Dividend Yield
  • PSNL N/A
  • BXC N/A
  • EPS Growth
  • PSNL N/A
  • BXC N/A
  • EPS
  • PSNL N/A
  • BXC 3.42
  • Revenue
  • PSNL $80,317,000.00
  • BXC $2,947,258,000.00
  • Revenue This Year
  • PSNL N/A
  • BXC $1.54
  • Revenue Next Year
  • PSNL $29.83
  • BXC $4.30
  • P/E Ratio
  • PSNL N/A
  • BXC $20.68
  • Revenue Growth
  • PSNL 0.36
  • BXC N/A
  • 52 Week Low
  • PSNL $2.83
  • BXC $63.14
  • 52 Week High
  • PSNL $10.95
  • BXC $134.79
  • Technical
  • Relative Strength Index (RSI)
  • PSNL 66.38
  • BXC 42.41
  • Support Level
  • PSNL $9.40
  • BXC $71.36
  • Resistance Level
  • PSNL $9.93
  • BXC $73.71
  • Average True Range (ATR)
  • PSNL 0.86
  • BXC 2.23
  • MACD
  • PSNL 0.00
  • BXC 0.22
  • Stochastic Oscillator
  • PSNL 70.66
  • BXC 18.42

About PSNL Personalis Inc.

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

About BXC Bluelinx Holdings Inc.

BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.

Share on Social Networks: